GRD Biotechnology Acquisition Limited (CGRD)

GRD Biotechnology Acquisition will go public soon, but the exact IPO date is still unknown.
IPO Price
Shares Offered
Deal Size
Chart not available yet
Data will show when the stock starts trading.
Market Cap 70.00M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 7.00M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About CGRD

GRD Biotechnology Acquisition Limited is a newly incorporated blank check company, incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to focus our search in the Asian biotechnology sector. [Read more]

Industry Shell Companies
Sector Financials
Founded 2023
Country China
Stock Exchange NASDAQ
Ticker Symbol CGRD
Full Company Profile


SPAC GRD Biotechnology Acquisition files for a $40 million IPO, targeting biotechs in Asia

GRD Biotechnology Acquisition, a blank check company targeting the biotech sector in Asia, filed on Wednesday with the SEC to raise up to $40 million in an initial public offering.

1 year ago - Renaissance Capital

New SPAC: GRD Biotechnology Acquisition Limited Files for $40M IPO

GRD Biotechnology (NASDAQ: CGRD) submitted its S-1 filing for a $40 million IPO this afternoon, marking the third SPAC to file in July.

1 year ago - SPACInsider

GRD Biotechnology Acquisition IPO Registration Document (S-1)

GRD Biotechnology Acquisition has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC